# Efficacy Study of High Dose Symlin to Treat Type 2 Diabetes Mellitus

> **NCT01137695** · PHASE3 · UNKNOWN · sponsor: **Cheryl Rosenfeld, DO** · enrollment: 40 (estimated)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Pramlintide
- **DRUG:** Pramlintide
- **DRUG:** Pramlintide
- **DRUG:** Pramlintide

## Key facts

- **NCT ID:** NCT01137695
- **Lead sponsor:** Cheryl Rosenfeld, DO
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-05
- **Primary completion:** 2012-01
- **Final completion:** 2012-04
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2011-10-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01137695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01137695, "Efficacy Study of High Dose Symlin to Treat Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01137695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*